• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床医生应对药物相互作用的方法。

The clinician's approach to drug interactions.

作者信息

Morrelli H F, Melmon K L

出版信息

Calif Med. 1968 Nov;109(5):380-9.

PMID:4881984
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1503319/
Abstract

Drug interactions are important causes of both unexpected toxic and therapeutic effects. Adverse reactions due to drug interaction are proportional to the number of drugs given and the duration of administration. Although drug interactions may be beneficial, they are most often recognized when they increase mortality or morbidity. The frequency of adverse drug interactions in clinical practice makes it mandatory for physicians to know the drugs and mechanisms involved.A drug may potentiate or antagonize the effects of another drug by direct chemical or physical combination, by altering gastrointestinal absorption, by influencing metabolism, transport, or renal clearance, by changing the activity of a drug at its receptor site, or by modifying the patient's response to the drug by a variety of means. This article stresses the importance of avoiding multible drug therapy. When such treatment is unavoidable, patients must be carefully observed for evidence of intensified or diminished drug effect. Only this permits the detection and prevention of untoward drug interactions.

摘要

药物相互作用是导致意外毒性和治疗效果的重要原因。药物相互作用引起的不良反应与给药数量和给药持续时间成正比。尽管药物相互作用可能有益,但它们最常被认识到的时候是在增加死亡率或发病率的时候。临床实践中药物不良反应相互作用的频率使得医生必须了解所涉及的药物和机制。一种药物可能通过直接化学或物理结合、改变胃肠道吸收、影响代谢、转运或肾脏清除、改变药物在其受体部位的活性,或通过多种方式改变患者对药物的反应,来增强或拮抗另一种药物的作用。本文强调避免多种药物治疗的重要性。当这种治疗不可避免时,必须仔细观察患者,以寻找药物效果增强或减弱的证据。只有这样才能检测和预防不良药物相互作用。

相似文献

1
The clinician's approach to drug interactions.临床医生应对药物相互作用的方法。
Calif Med. 1968 Nov;109(5):380-9.
2
Drug interactions.药物相互作用。
Proc West Pharmacol Soc. 1969;12:87-95.
3
[Drug interaction].[药物相互作用]
Klin Med (Mosk). 1984 Jun;62(6):9-16.
4
Drug Interactions.药物相互作用。
Pa Med. 1969 Dec;72(12):40-4.
5
Drug interactions.药物相互作用。
Am Fam Physician. 1983 Feb;27(2):229-38.
6
The application of basic principles of drug interaction to clinical practice.
J Urol. 1975 Jan;113(1):100-7. doi: 10.1016/s0022-5347(17)59418-5.
7
Drug interactions and clinical pharmacokinetics.药物相互作用与临床药代动力学。
Clin Pharmacokinet. 1976;1(5):351-72. doi: 10.2165/00003088-197601050-00003.
8
[Drug interaction].
Pol Tyg Lek. 1971 May 31;26(22):838-41.
9
Drug interactions in podiatric medicine.
J Am Podiatry Assoc. 1972 Feb;62(2):43-52. doi: 10.7547/87507315-62-2-43.
10
Drug interactions.药物相互作用。
Am J Pharm Sci Support Public Health. 1973 May-Jun;145(3):65-116.

引用本文的文献

1
Pharmacogenetics.药物遗传学
Calif Med. 1969 Oct;111(4):312-3.
2
Drug interactions.药物相互作用。
Calif Med. 1972 Sep;117(3):80-1.
3
Drug interaction in anaesthesia. A review.麻醉中的药物相互作用。综述。
Can Anaesth Soc J. 1971 Jul;18(4):353-75. doi: 10.1007/BF03025688.
4
Pharmacodynamic and pharmacokinetic drug interactions with coumarin anticoagulants.香豆素类抗凝剂的药效学和药代动力学药物相互作用。
Drugs. 1976;11(6):461-70. doi: 10.2165/00003495-197611060-00006.

本文引用的文献

1
Hazards of New Drugs: The scientific approach is necessary for the safest and most effective use of new drugs.新药的危害:为了最安全、最有效地使用新药,科学方法是必要的。
Science. 1963 Mar 22;139(3560):1180-5. doi: 10.1126/science.139.3560.1180.
2
STUDIES ON THE CHEMOTHERAPY OF THE HUMAN MALARIAS. VIII. THE PHYSIOLOGICAL DISPOSITION OF PAMAQUINE.人体疟疾化学疗法研究。VIII. 帕马喹的生理处置
J Clin Invest. 1948 May;27(3 Pt 2):114-20. doi: 10.1172/JCI101948.
3
DRUG TOXICITY IN MAN: THE PROBLEM AND THE CHALLENGE.人类药物毒性:问题与挑战
Ann N Y Acad Sci. 1965 Mar 12;123:312-5. doi: 10.1111/j.1749-6632.1965.tb12271.x.
4
THE GENETICS OF ABNORMAL DRUG RESPONSES.
Ann N Y Acad Sci. 1965 Mar 12;123:167-77. doi: 10.1111/j.1749-6632.1965.tb12254.x.
5
PREMEDICATION--A REASSESSMENT.术前用药——重新评估
Proc R Soc Med. 1965 Jan;58(1):29-32. doi: 10.1177/003591576505800108.
6
ERRORS OF COMPLEX PRESCRIBING.
Lancet. 1965 Feb 13;1(7381):370-3. doi: 10.1016/s0140-6736(65)91799-x.
7
QUINIDINE SYNCOPE. PAROXYSMAL VENTRICULAR FIBRILLATION OCCURRING DURING TREATMENT OF CHRONIC ATRIAL ARRHYTHMIAS.奎尼丁晕厥。慢性房性心律失常治疗期间发生的阵发性室性颤动。
Circulation. 1964 Jul;30:17-26. doi: 10.1161/01.cir.30.1.17.
8
MONOAMINE OXIDASE INHIBITORS, TYRAMINE, AND CHESSE.单胺氧化酶抑制剂、酪胺与奶酪
JAMA. 1964 Jun 29;188:1108-10. doi: 10.1001/jama.1964.03060390010002.
9
POTENTIATION OF ANTICOAGULANTS CAUSED BY PYRAZOLE COMPOUNDS.吡唑化合物引起的抗凝剂增效作用。
JAMA. 1964 Apr 20;188:320-1. doi: 10.1001/jama.1964.03060290124046.
10
INFLUENCE OF RESERPINE AND BETA TM 10 ON DIGITALIS-INDUCED VENTRICULAR ARRHYTHMIA.
Circ Res. 1963 Aug;13:149-58. doi: 10.1161/01.res.13.2.149.